Skye Bioscience Inc. is a biotechnology company focused on the development of innovative therapeutics derived from cannabis. The company leverages its expertise in cannabinoid research to create new treatment options targeting various medical conditions, with a particular emphasis on addressing unmet needs in the fields of pain management and ocular diseases. By harnessing the potential of cannabinoid compounds, Skye aims to enhance patients' quality of life through breakthrough therapies that utilize natural plant-based ingredients. The company's mission revolves around advancing scientific understanding and unlocking the therapeutic benefits of cannabis to improve health outcomes. Read More
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.
Skye shares surge after new data shows nimacimab reduces weight over 30% with tirzepatide, with stable potency and promising obesity treatment potential.
